Book PTEN Gene Mutation Test in Saudi Arabia | Lahalak Medical Platform

Protect your health with advanced PTEN gene testing. This molecular analysis accurately differentiates between atypical hyperplasia and early-stage endometrial cancer, ensuring you receive the most effective and timely medical intervention.

Scientific name: PTEN Gene Mutation Testing for Uterine Tumors

An advanced molecular test designed to detect alterations in the PTEN gene. It is crucial for diagnosing uterine tumors and differentiating between atypical endometrial hyperplasia and early-stage cancer.

PTEN Gene Mutation Testing for Uterine Tumors - Early Uterine Cancer Detection
Service type Molecular laboratory test
Duration 15-20 minutes
Fasting Fasting is not required

Included Services

  • Sample collection
  • PTEN protein genetic sequencing
  • Detailed medical consultant report

Medical Service Information

Purpose of Testing

  • Differentiate between benign hyperplasia and malignant tumors.
  • Assess the risk of progression to endometrial cancer.
  • Support decisions regarding surgery or hormonal therapy.

Target Groups

  • Women experiencing abnormal uterine bleeding.
  • Patients diagnosed with atypical endometrial hyperplasia.
  • Individuals with a strong family history of gynecological cancers.

Clinical Significance

  • PTEN loss is a strong indicator of early neoplastic transformation.
  • Results guide personalized monitoring and surveillance plans.
  • Reduces unnecessary surgical interventions in benign cases.

Conditions & Notices

  • Previous endometrial medical reports are recommended

Medical services you might also like